Discover 476 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 476
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Wyoming MI, Flint MI, Milwaukee WI, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
for
Fuchs Endothelial Corneal Dystrophy, Fuchs
Location: Grand Rapids MI, Indianapolis IN
Sponsor: Design Therapeutics, Inc.
Sex: All
Age: 30+
Code: NCT07024693
Phase2, Recruiting
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Location: Grand Rapids MI, Detroit MI, Madison WI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06586515
Phase1, Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
for
Solid Tumors
Location: Grand Rapids MI, Minneapolis MN, Fairfax VA, Houston TX,
Sponsor: Adcentrx Therapeutics
Sex: All
Age: 18+
Code: NCT06710379
Phase1, Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
for
Colorectal Neoplasms, Gastrointestinal Neoplasms
Location: Grand Rapids MI, Indianapolis IN, Aurora CO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06663319
Phase1, Recruiting
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
for
Gastrointestinal Stromal Tumor (GIST)
Location: Grand Rapids MI, Rochester MN, Nashville TN,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06630234
Phase1, Phase2, Recruiting
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
for
Solid Tumor
Location: Grand Rapids MI, Fairfax VA, Boston MA, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06797336
Phase1, Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for
Ovarian Cancer, Solid Tumor
Location: Grand Rapids MI, Nashville TN, Denver CO, Fairfax VA,
Sponsor: OnCusp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06234423
Phase1, Recruiting
A Study of JNJ-87890387 for Advanced Solid Tumors
for
Neoplasms, Advanced Solid Tumors
Location: Grand Rapids MI, Nashville TN
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06178614
Phase1, Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Grand Rapids MI, Fairfax VA, Irving TX, Austin TX,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase1, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Grand Rapids MI, Cleveland OH, Columbus OH,
Location: Grand Rapids MI, Detroit MI, Columbus OH, Pittsburgh PA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase1, Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Grand Rapids MI, Ann Arbor MI, Arlington Heights IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Grand Rapids MI, Columbus OH, New York NY, Mineola NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06400472
Phase1, Recruiting
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
for
Solid Tumor
Location: Grand Rapids MI, Scottsdale AZ
Sponsor: Qualigen Theraputics, Inc.
Sex: All
Age: 18+
Code: NCT06086522
Phase1, Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer